Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Generic Tazarotene Cream vs Tazorac in Acne Vulgaris
NCT02160678Phase 3Completed
- Sponsor
- G&W Laboratories
- Start
- May 2014
- Primary completion
- Jul 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tazarotene in acne vulgaris, sponsored by G&W Laboratories. Started May 2014; status: completed.
02
Drugs
tazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02160678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160678.